+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dental Bone Graft Substitutes Market Size, Share & COVID-19 Impact Analysis Europe 2021-2027, Includes: Allografts, Xenografts, Synthetics, Dental Growth Factors & Dental Barrier Membranes

  • PDF Icon

    Report

  • 228 Pages
  • June 2021
  • Region: Europe
  • iData Research
  • ID: 5440473
Throughout this medical market research, the publisher analysed more than 50 European companies and utilized comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.

EUROPE RESEARCH SCOPE


Regions:

  • Germany,
  • France,
  • United Kingdom,
  • Italy,
  • Spain,
  • Benelux,
  • Scandinavia,
  • Austria,
  • Switzerland,
  • Portugal.

Base Year: 2020

Forecast: 2021-2027

Historical Data: 2017-2020

Quantitative Coverage:

  • Market Size,
  • Market Shares,
  • Market Forecasts,
  • Market Growth Rates,
  • Units Sold,
  • Average Selling Prices.

Qualitative Coverage

  • COVID19 Impact,
  • Market Growth Trends,
  • Market Limiters,
  • Competitive Analysis & SWOT for Top Competitors,
  • Mergers & Acquisitions,
  • Company Profiles,
  • Product Portfolios,

Data Sources

  • Primary Interviews with Industry Leaders,
  • Government Physician Data,
  • Regulatory Data,
  • Hospital Private Data,
  • Import & Export Data,
  • Internal Database.

Markets Covered

  • Dental Bone Graft Substitutes Market- MedCore - The market for dental bone graft substitutes is segmented into allograft, xenograft, and synthetic markets.
  • Dental Growth Factor Market - MedCore - The market for dental growth factor is comprised of the Emdogain market.
  • Dental Barrier Membranes Market - MedCore - The market for dental barrier membranes is separated into resorbable and non-resorbable membrane markets.

Key Market Insights


Overall, the EU dental bone graft substitutes market size is projected to reach over €151 million by 2027.

Both patient demand and a growing number of general practitioners (GPs) placing implants are driving the European market for dental bone graft substitutes forward by increasing the volume of dental implant procedures. Under this scenario, there is an increase in the probability that a patient is informed on the importance of having a sufficient level of bone in their jaw before the procedure. Ultimately, this will result in a greater number of patient referrals to specialists for dental regenerative procedures that incorporate dental biomaterials.

Even under the presence of limiting regulatory barriers, allograft products are showing double-digit growth in Europe and demand is forecasted to grow through 2027.

Currently, the majority of the market share is controlled by two main competitors - Geistlich and Botiss Biomaterials.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ACE Surgical
  • Alpha-Bio Tec
  • Anthogyr
  • Artoss
  • Augma Biomaterials
  • BEGO
  • Bicon Dental Implants
  • BIOBank
  • BioHorizons
  • Biomatlante
  • Bioteck
  • Botiss Biomaterials
  • Cells + Tissuebank Austria
  • Cortex Dental
  • Curasan
  • Datum Dental
  • Degradable Solutions
  • Dentegris
  • Dentsply Sirona
  • Envista
  • Euroteknika
  • Geistlich
  • Halma
  • Henry Schein
  • Implant Direct
  • Kasios
  • Keramat
  • Keystone Dental
  • LifeNet Health
  • Medtronic
  • MegaGen
  • MIS Implants
  • Neoss
  • Nobel Biocare
  • Non-Profit Tissue Banks
  • Noraker
  • NovaBone
  • OST Development
  • Osteogenics Biomedical
  • OsteoBiol
  • OT Medical
  • Paltop Dental Solutions
  • Resorba
  • Rocky Mountain Tissue Bank (RMTB)
  • Straumann Group
  • Tecnoss
  • Zimmer Biomet